These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20518489)

  • 1. Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.
    Tzanopoulou S; Sagnou M; Paravatou-Petsotas M; Gourni E; Loudos G; Xanthopoulos S; Lafkas D; Kiaris H; Varvarigou A; Pirmettis IC; Papadopoulos M; Pelecanou M
    J Med Chem; 2010 Jun; 53(12):4633-41. PubMed ID: 20518489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M = Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.
    Tzanopoulou S; Pirmettis IC; Patsis G; Paravatou-Petsotas M; Livaniou E; Papadopoulos M; Pelecanou M
    J Med Chem; 2006 Sep; 49(18):5408-10. PubMed ID: 16942013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
    Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
    Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
    Shi DF; Bradshaw TD; Wrigley S; McCall CJ; Lelieveld P; Fichtner I; Stevens MF
    J Med Chem; 1996 Aug; 39(17):3375-84. PubMed ID: 8765521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C; Schubiger PA; Schibli R
    Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
    Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
    Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
    Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
    Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).
    Bowen ML; Lim NC; Ewart CB; Misri R; Ferreira CL; Häfeli U; Adam MJ; Orvig C
    Dalton Trans; 2009 Nov; (42):9216-27. PubMed ID: 20449199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
    J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
    Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
    J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents.
    Maria L; Cunha S; Videira M; Gano L; Paulo A; Santos IC; Santos I
    Dalton Trans; 2007 Jul; (28):3010-9. PubMed ID: 17622418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of Re/
    Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
    Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).
    Aiello S; Wells G; Stone EL; Kadri H; Bazzi R; Bell DR; Stevens MF; Matthews CS; Bradshaw TD; Westwell AD
    J Med Chem; 2008 Aug; 51(16):5135-9. PubMed ID: 18666770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
    J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates.
    Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM
    J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
    Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
    Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.
    Vivier M; Rapp M; Papon J; Labarre P; Galmier MJ; Sauzière J; Madelmont JC
    J Med Chem; 2008 Feb; 51(4):1043-7. PubMed ID: 18237109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.